What Are the Future Directions for Flow Cytometry in Cancer?
The future of flow cytometry in cancer is promising, with ongoing advancements aimed at increasing its sensitivity, specificity, and throughput. Emerging technologies, such as mass cytometry (CyTOF), combine flow cytometry with mass spectrometry to analyze dozens of markers simultaneously. Additionally, the integration of flow cytometry with other technologies, such as next-generation sequencing and single-cell RNA sequencing, holds the potential to provide deeper insights into the molecular landscape of cancer.
